Aaron J Schetter
Overview
Explore the profile of Aaron J Schetter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
4741
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oliner K, Shiller M, Schmid P, Ratcliffe M, Schetter A, Tsao M
Clin Cancer Res
. 2024 Dec;
31(5):795-800.
PMID: 39724199
A companion diagnostic is a diagnostic test that provides information essential for the safe and effective use of a corresponding therapeutic product. To obtain marketing approval, the companion diagnostic must...
2.
Noro R, Ishigame T, Walsh N, Shiraishi K, Robles A, Ryan B, et al.
J Thorac Oncol
. 2016 Sep;
12(1):65-76.
PMID: 27613525
Introduction: There are no validated molecular methods that prospectively identify patients with surgically resected lung squamous cell carcinoma (SCC) at high risk for recurrence. By focusing on the expression of...
3.
Wang J, Yang S, He P, Schetter A, Gaedcke J, Ghadimi B, et al.
Clin Cancer Res
. 2016 Jul;
22(24):5992-6001.
PMID: 27401251
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is refractory to available treatments. Delineating critical pathways, responsible for disease aggressiveness and therapeutic resistance, may identify effective therapeutic targets. We aimed to identify key...
4.
Wang J, He P, Gaida M, Yang S, Schetter A, Gaedcke J, et al.
Oncotarget
. 2016 Jul;
7(33):52993-53004.
PMID: 27367029
Pancreatic cancer is one of the most lethal malignancies and is refractory to the available treatments. Pancreatic ductal adenocarcinoma (PDAC) expresses high level of inducible nitric oxide synthase (NOS2), which...
5.
Robles A, Arai E, Mathe E, Okayama H, Schetter A, Brown D, et al.
J Thorac Oncol
. 2015 Jul;
10(7):1037-48.
PMID: 26134223
Introduction: Up to 30% stage I lung cancer patients suffer recurrence within 5 years of curative surgery. We sought to improve existing protein-coding gene and microRNA expression prognostic classifiers by...
6.
Hiyoshi Y, Schetter A, Okayama H, Inamura K, Anami K, Nguyen G, et al.
PLoS One
. 2015 Apr;
10(4):e0124899.
PMID: 25894979
The microRNA-34 family (miR-34a, -34b and -34c) have been reported to be tumor suppressor microRNAs (miRNAs) that are regulated by the TP53 and DNA hypermethylation. However, the expression, regulation, and...
7.
Hur K, Toiyama Y, Schetter A, Okugawa Y, Harris C, Boland C, et al.
J Natl Cancer Inst
. 2015 Feb;
107(3).
PMID: 25663689
Background: Distant metastasis is the major cause of mortality in colorectal cancer (CRC). We performed a systemic, comprehensive discovery for expression patterns of metastasis-specific microRNAs (miRNAs) by directly comparing primary...
8.
Okayama H, Schetter A, Ishigame T, Robles A, Kohno T, Yokota J, et al.
Cancer Epidemiol Biomarkers Prev
. 2014 Sep;
23(12):2884-94.
PMID: 25242053
Background: We previously developed a prognostic classifier using the expression levels of BRCA1, HIF1A, DLC1, and XPO1 that identified stage I lung adenocarcinoma patients with a high risk of relapse....
9.
Saito M, Shiraishi K, Matsumoto K, Schetter A, Ogata-Kawata H, Tsuchiya N, et al.
Clin Cancer Res
. 2014 Aug;
20(18):4784-93.
PMID: 25142144
Purpose: To examine the clinical utility of intratumor microRNAs (miRNA) as a biomarker for predicting responses to platinum-based doublet chemotherapy in patients with recurring lung adenocarcinoma (LADC). Experimental Design: The...
10.
Nguyen G, Tang W, Robles A, Beyer R, Gray L, Welsh J, et al.
Proc Natl Acad Sci U S A
. 2014 Jun;
111(27):9905-10.
PMID: 24958861
Bloom syndrome is a rare autosomal recessive disorder characterized by genetic instability and cancer predisposition, and caused by mutations in the gene encoding the Bloom syndrome, RecQ helicase-like (BLM) protein....